nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—CYP2C9—Ifosfamide—germ cell cancer	0.0894	0.377	CbGbCtD
Bexarotene—CYP3A4—Ifosfamide—germ cell cancer	0.052	0.219	CbGbCtD
Bexarotene—CYP2C9—Cisplatin—germ cell cancer	0.0435	0.183	CbGbCtD
Bexarotene—CYP3A4—Vinblastine—germ cell cancer	0.0276	0.116	CbGbCtD
Bexarotene—CYP2C9—cardial valve—germ cell cancer	0.0264	0.165	CbGeAlD
Bexarotene—CYP3A4—Etoposide—germ cell cancer	0.0249	0.105	CbGbCtD
Bexarotene—RXRG—Nuclear Receptors—NR0B1—germ cell cancer	0.0172	0.0797	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptors—NR0B1—germ cell cancer	0.0161	0.0749	CbGpPWpGaD
Bexarotene—RXRA—ganglion—germ cell cancer	0.016	0.0998	CbGeAlD
Bexarotene—RXRG—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.0136	0.0629	CbGpPWpGaD
Bexarotene—RXRG—Regulation of Androgen receptor activity—NR0B1—germ cell cancer	0.0131	0.061	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.0127	0.0592	CbGpPWpGaD
Bexarotene—RXRB—Regulation of Androgen receptor activity—NR0B1—germ cell cancer	0.0124	0.0574	CbGpPWpGaD
Bexarotene—RXRA—Import of palmitoyl-CoA into the mitochondrial matrix—CRABP1—germ cell cancer	0.00942	0.0437	CbGpPWpGaD
Bexarotene—RXRG—a6b1 and a6b4 Integrin signaling—CD9—germ cell cancer	0.00861	0.04	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptors—NR0B1—germ cell cancer	0.0084	0.039	CbGpPWpGaD
Bexarotene—RXRB—a6b1 and a6b4 Integrin signaling—CD9—germ cell cancer	0.00809	0.0376	CbGpPWpGaD
Bexarotene—RXRG—neck—germ cell cancer	0.00798	0.0499	CbGeAlD
Bexarotene—RXRA—Regulation of pyruvate dehydrogenase (PDH) complex—CRABP1—germ cell cancer	0.00798	0.037	CbGpPWpGaD
Bexarotene—RXRG—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.00738	0.0343	CbGpPWpGaD
Bexarotene—RXRB—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.00694	0.0322	CbGpPWpGaD
Bexarotene—RXRG—trigeminal ganglion—germ cell cancer	0.00689	0.0431	CbGeAlD
Bexarotene—RXRA—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.00664	0.0308	CbGpPWpGaD
Bexarotene—RXRA—Regulation of Androgen receptor activity—NR0B1—germ cell cancer	0.00644	0.0299	CbGpPWpGaD
Bexarotene—RXRA—telencephalon—germ cell cancer	0.00616	0.0385	CbGeAlD
Bexarotene—RXRG—eye—germ cell cancer	0.00594	0.0371	CbGeAlD
Bexarotene—RXRA—Pyruvate metabolism—CRABP1—germ cell cancer	0.00577	0.0268	CbGpPWpGaD
Bexarotene—CYP2C9—urine—germ cell cancer	0.00568	0.0355	CbGeAlD
Bexarotene—RXRB—telencephalon—germ cell cancer	0.00509	0.0318	CbGeAlD
Bexarotene—RXRB—decidua—germ cell cancer	0.00482	0.0301	CbGeAlD
Bexarotene—RXRG—pituitary gland—germ cell cancer	0.00441	0.0275	CbGeAlD
Bexarotene—CYP3A4—urine—germ cell cancer	0.00433	0.0271	CbGeAlD
Bexarotene—RXRG—medulla oblongata—germ cell cancer	0.00425	0.0266	CbGeAlD
Bexarotene—RXRA—a6b1 and a6b4 Integrin signaling—CD9—germ cell cancer	0.00422	0.0196	CbGpPWpGaD
Bexarotene—RXRA—female gonad—germ cell cancer	0.00418	0.0261	CbGeAlD
Bexarotene—RXRG—adrenal gland—germ cell cancer	0.00394	0.0246	CbGeAlD
Bexarotene—RXRA—endocrine gland—germ cell cancer	0.00389	0.0243	CbGeAlD
Bexarotene—RXRG—midbrain—germ cell cancer	0.00389	0.0243	CbGeAlD
Bexarotene—RXRA—head—germ cell cancer	0.00384	0.024	CbGeAlD
Bexarotene—RXRG—spinal cord—germ cell cancer	0.00379	0.0237	CbGeAlD
Bexarotene—RXRB—adrenal gland—germ cell cancer	0.0037	0.0231	CbGeAlD
Bexarotene—RXRA—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.00362	0.0168	CbGpPWpGaD
Bexarotene—RXRA—Pyruvate metabolism and Citric Acid (TCA) cycle—CRABP1—germ cell cancer	0.00349	0.0162	CbGpPWpGaD
Bexarotene—RXRB—female gonad—germ cell cancer	0.00345	0.0216	CbGeAlD
Bexarotene—RXRG—endocrine gland—germ cell cancer	0.00341	0.0213	CbGeAlD
Bexarotene—RXRG—head—germ cell cancer	0.00337	0.0211	CbGeAlD
Bexarotene—RXRG—testis—germ cell cancer	0.00326	0.0203	CbGeAlD
Bexarotene—RXRB—endocrine gland—germ cell cancer	0.00321	0.0201	CbGeAlD
Bexarotene—RXRB—head—germ cell cancer	0.00317	0.0198	CbGeAlD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—KLF4—germ cell cancer	0.00314	0.0146	CbGpPWpGaD
Bexarotene—RXRB—testis—germ cell cancer	0.00306	0.0191	CbGeAlD
Bexarotene—RXRB—cerebellum—germ cell cancer	0.00283	0.0177	CbGeAlD
Bexarotene—RXRA—brain—germ cell cancer	0.00278	0.0174	CbGeAlD
Bexarotene—RXRG—brain—germ cell cancer	0.00244	0.0153	CbGeAlD
Bexarotene—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—germ cell cancer	0.00234	0.0109	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—NR0B1—germ cell cancer	0.00234	0.0109	CbGpPWpGaD
Bexarotene—RXRB—brain—germ cell cancer	0.0023	0.0143	CbGeAlD
Bexarotene—RXRB—Generic Transcription Pathway—NR0B1—germ cell cancer	0.0022	0.0102	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—NAT9—germ cell cancer	0.00201	0.00935	CbGpPWpGaD
Bexarotene—RXRA—Circadian Clock—AVP—germ cell cancer	0.00171	0.00792	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—SLC2A3—germ cell cancer	0.00169	0.00787	CbGpPWpGaD
Bexarotene—RXRA—The citric acid (TCA) cycle and respiratory electron transport—CRABP1—germ cell cancer	0.00135	0.00628	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.00133	0.00617	CbGpPWpGaD
Bexarotene—RXRG—a6b1 and a6b4 Integrin signaling—HRAS—germ cell cancer	0.00123	0.00573	CbGpPWpGaD
Bexarotene—RXRA—PPAR Alpha Pathway—MYC—germ cell cancer	0.00119	0.00554	CbGpPWpGaD
Bexarotene—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—germ cell cancer	0.00116	0.00539	CbGpPWpGaD
Bexarotene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	0.00115	0.00534	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TDGF1—germ cell cancer	0.00115	0.00533	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—NR0B1—germ cell cancer	0.00115	0.00533	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—NR0B1—germ cell cancer	0.00113	0.00523	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—NR0B1—germ cell cancer	0.00106	0.00492	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—DNMT3L—germ cell cancer	0.000977	0.00454	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—SALL4—germ cell cancer	0.000977	0.00454	CbGpPWpGaD
Bexarotene—CYP2C9—endocrine gland—germ cell cancer	0.000943	0.00589	CbGeAlD
Bexarotene—RXRA—Developmental Biology—NANOG—germ cell cancer	0.000936	0.00435	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—DNMT3L—germ cell cancer	0.000919	0.00427	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—RARS—germ cell cancer	0.000909	0.00422	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—POU5F1—germ cell cancer	0.000901	0.00419	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—RARS—germ cell cancer	0.000854	0.00397	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000829	0.00385	CbGpPWpGaD
Bexarotene—CYP3A4—endocrine gland—germ cell cancer	0.000719	0.00449	CbGeAlD
Bexarotene—RXRA—Developmental Biology—KLF4—germ cell cancer	0.00071	0.0033	CbGpPWpGaD
Bexarotene—Discomfort—Dactinomycin—germ cell cancer	0.00068	0.00176	CcSEcCtD
Bexarotene—Anorexia—Bleomycin—germ cell cancer	0.000674	0.00174	CcSEcCtD
Bexarotene—Hypoaesthesia—Etoposide—germ cell cancer	0.000668	0.00173	CcSEcCtD
Bexarotene—Malaise—Ifosfamide—germ cell cancer	0.000668	0.00172	CcSEcCtD
Bexarotene—Vertigo—Ifosfamide—germ cell cancer	0.000665	0.00172	CcSEcCtD
Bexarotene—Urinary tract disorder—Etoposide—germ cell cancer	0.000663	0.00171	CcSEcCtD
Bexarotene—Leukopenia—Ifosfamide—germ cell cancer	0.000663	0.00171	CcSEcCtD
Bexarotene—Polyuria—Methotrexate—germ cell cancer	0.000662	0.00171	CcSEcCtD
Bexarotene—Abdominal pain—Vinblastine—germ cell cancer	0.000662	0.00171	CcSEcCtD
Bexarotene—Oedema—Dactinomycin—germ cell cancer	0.000659	0.0017	CcSEcCtD
Bexarotene—Urethral disorder—Etoposide—germ cell cancer	0.000658	0.0017	CcSEcCtD
Bexarotene—Infection—Dactinomycin—germ cell cancer	0.000655	0.00169	CcSEcCtD
Bexarotene—Arrhythmia—Cisplatin—germ cell cancer	0.000655	0.00169	CcSEcCtD
Bexarotene—Palpitations—Ifosfamide—germ cell cancer	0.000654	0.00169	CcSEcCtD
Bexarotene—Alopecia—Cisplatin—germ cell cancer	0.000648	0.00167	CcSEcCtD
Bexarotene—Hepatic failure—Methotrexate—germ cell cancer	0.000647	0.00167	CcSEcCtD
Bexarotene—Cough—Ifosfamide—germ cell cancer	0.000646	0.00167	CcSEcCtD
Bexarotene—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000646	0.00167	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000644	0.00166	CcSEcCtD
Bexarotene—Hypertension—Ifosfamide—germ cell cancer	0.000639	0.00165	CcSEcCtD
Bexarotene—Erythema—Cisplatin—germ cell cancer	0.000638	0.00165	CcSEcCtD
Bexarotene—Malnutrition—Cisplatin—germ cell cancer	0.000638	0.00165	CcSEcCtD
Bexarotene—Paraesthesia—Bleomycin—germ cell cancer	0.000635	0.00164	CcSEcCtD
Bexarotene—Dyspnoea—Bleomycin—germ cell cancer	0.00063	0.00163	CcSEcCtD
Bexarotene—Myalgia—Ifosfamide—germ cell cancer	0.00063	0.00163	CcSEcCtD
Bexarotene—Chest pain—Ifosfamide—germ cell cancer	0.00063	0.00163	CcSEcCtD
Bexarotene—Arthralgia—Ifosfamide—germ cell cancer	0.00063	0.00163	CcSEcCtD
Bexarotene—Flatulence—Cisplatin—germ cell cancer	0.000629	0.00162	CcSEcCtD
Bexarotene—Anorexia—Dactinomycin—germ cell cancer	0.000628	0.00162	CcSEcCtD
Bexarotene—Eye disorder—Etoposide—germ cell cancer	0.000628	0.00162	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000626	0.00162	CcSEcCtD
Bexarotene—Cardiac disorder—Etoposide—germ cell cancer	0.000623	0.00161	CcSEcCtD
Bexarotene—Discomfort—Ifosfamide—germ cell cancer	0.000623	0.00161	CcSEcCtD
Bexarotene—Hypersensitivity—Vinblastine—germ cell cancer	0.000617	0.00159	CcSEcCtD
Bexarotene—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000616	0.00159	CcSEcCtD
Bexarotene—Decreased appetite—Bleomycin—germ cell cancer	0.000615	0.00159	CcSEcCtD
Bexarotene—Muscle spasms—Cisplatin—germ cell cancer	0.000614	0.00158	CcSEcCtD
Bexarotene—Angiopathy—Etoposide—germ cell cancer	0.000609	0.00157	CcSEcCtD
Bexarotene—Confusional state—Ifosfamide—germ cell cancer	0.000609	0.00157	CcSEcCtD
Bexarotene—Pain—Bleomycin—germ cell cancer	0.000605	0.00156	CcSEcCtD
Bexarotene—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—germ cell cancer	0.000604	0.00281	CbGpPWpGaD
Bexarotene—Oedema—Ifosfamide—germ cell cancer	0.000604	0.00156	CcSEcCtD
Bexarotene—Chills—Etoposide—germ cell cancer	0.000603	0.00156	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000601	0.00155	CcSEcCtD
Bexarotene—Asthenia—Vinblastine—germ cell cancer	0.000601	0.00155	CcSEcCtD
Bexarotene—Infection—Ifosfamide—germ cell cancer	0.0006	0.00155	CcSEcCtD
Bexarotene—Alopecia—Etoposide—germ cell cancer	0.000594	0.00153	CcSEcCtD
Bexarotene—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000593	0.00153	CcSEcCtD
Bexarotene—Lethargy—Methotrexate—germ cell cancer	0.000593	0.00153	CcSEcCtD
Bexarotene—Nervous system disorder—Ifosfamide—germ cell cancer	0.000593	0.00153	CcSEcCtD
Bexarotene—Ill-defined disorder—Cisplatin—germ cell cancer	0.000592	0.00153	CcSEcCtD
Bexarotene—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000592	0.00153	CcSEcCtD
Bexarotene—Anaemia—Cisplatin—germ cell cancer	0.00059	0.00152	CcSEcCtD
Bexarotene—Skin disorder—Ifosfamide—germ cell cancer	0.000587	0.00152	CcSEcCtD
Bexarotene—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000584	0.00151	CcSEcCtD
Bexarotene—Feeling abnormal—Bleomycin—germ cell cancer	0.000583	0.0015	CcSEcCtD
Bexarotene—Osteoarthritis—Methotrexate—germ cell cancer	0.000582	0.0015	CcSEcCtD
Bexarotene—Anorexia—Ifosfamide—germ cell cancer	0.000576	0.00149	CcSEcCtD
Bexarotene—Malaise—Cisplatin—germ cell cancer	0.000576	0.00149	CcSEcCtD
Bexarotene—Decreased appetite—Dactinomycin—germ cell cancer	0.000573	0.00148	CcSEcCtD
Bexarotene—Diarrhoea—Vinblastine—germ cell cancer	0.000573	0.00148	CcSEcCtD
Bexarotene—Dysgeusia—Etoposide—germ cell cancer	0.000573	0.00148	CcSEcCtD
Bexarotene—Leukopenia—Cisplatin—germ cell cancer	0.000571	0.00148	CcSEcCtD
Bexarotene—Fatigue—Dactinomycin—germ cell cancer	0.000568	0.00147	CcSEcCtD
Bexarotene—Back pain—Etoposide—germ cell cancer	0.000566	0.00146	CcSEcCtD
Bexarotene—Pain—Dactinomycin—germ cell cancer	0.000564	0.00146	CcSEcCtD
Bexarotene—Muscle spasms—Etoposide—germ cell cancer	0.000562	0.00145	CcSEcCtD
Bexarotene—Body temperature increased—Bleomycin—germ cell cancer	0.000559	0.00144	CcSEcCtD
Bexarotene—Dizziness—Vinblastine—germ cell cancer	0.000554	0.00143	CcSEcCtD
Bexarotene—RXRA—Gene Expression—NR0B1—germ cell cancer	0.000552	0.00256	CbGpPWpGaD
Bexarotene—Mood swings—Methotrexate—germ cell cancer	0.000551	0.00142	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00055	0.00142	CcSEcCtD
Bexarotene—Ataxia—Methotrexate—germ cell cancer	0.000547	0.00141	CcSEcCtD
Bexarotene—Myalgia—Cisplatin—germ cell cancer	0.000543	0.0014	CcSEcCtD
Bexarotene—Feeling abnormal—Dactinomycin—germ cell cancer	0.000543	0.0014	CcSEcCtD
Bexarotene—Paraesthesia—Ifosfamide—germ cell cancer	0.000543	0.0014	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000543	0.00252	CbGpPWpGaD
Bexarotene—Ill-defined disorder—Etoposide—germ cell cancer	0.000543	0.0014	CcSEcCtD
Bexarotene—Anxiety—Cisplatin—germ cell cancer	0.000541	0.0014	CcSEcCtD
Bexarotene—Anaemia—Etoposide—germ cell cancer	0.00054	0.0014	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00054	0.00139	CcSEcCtD
Bexarotene—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000539	0.00139	CcSEcCtD
Bexarotene—Dyspnoea—Ifosfamide—germ cell cancer	0.000539	0.00139	CcSEcCtD
Bexarotene—Somnolence—Ifosfamide—germ cell cancer	0.000537	0.00139	CcSEcCtD
Bexarotene—Liver function test abnormal—Methotrexate—germ cell cancer	0.000537	0.00139	CcSEcCtD
Bexarotene—Discomfort—Cisplatin—germ cell cancer	0.000537	0.00139	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000534	0.00248	CbGpPWpGaD
Bexarotene—Vomiting—Vinblastine—germ cell cancer	0.000532	0.00137	CcSEcCtD
Bexarotene—Malaise—Etoposide—germ cell cancer	0.000527	0.00136	CcSEcCtD
Bexarotene—Vertigo—Etoposide—germ cell cancer	0.000525	0.00136	CcSEcCtD
Bexarotene—Decreased appetite—Ifosfamide—germ cell cancer	0.000525	0.00136	CcSEcCtD
Bexarotene—Headache—Vinblastine—germ cell cancer	0.000524	0.00135	CcSEcCtD
Bexarotene—Leukopenia—Etoposide—germ cell cancer	0.000523	0.00135	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000522	0.00135	CcSEcCtD
Bexarotene—Body temperature increased—Dactinomycin—germ cell cancer	0.000521	0.00135	CcSEcCtD
Bexarotene—Abdominal pain—Dactinomycin—germ cell cancer	0.000521	0.00135	CcSEcCtD
Bexarotene—Fatigue—Ifosfamide—germ cell cancer	0.000521	0.00135	CcSEcCtD
Bexarotene—Oedema—Cisplatin—germ cell cancer	0.000521	0.00135	CcSEcCtD
Bexarotene—Hypersensitivity—Bleomycin—germ cell cancer	0.000521	0.00135	CcSEcCtD
Bexarotene—Infection—Cisplatin—germ cell cancer	0.000517	0.00134	CcSEcCtD
Bexarotene—Constipation—Ifosfamide—germ cell cancer	0.000517	0.00133	CcSEcCtD
Bexarotene—Pain—Ifosfamide—germ cell cancer	0.000517	0.00133	CcSEcCtD
Bexarotene—Loss of consciousness—Etoposide—germ cell cancer	0.000514	0.00133	CcSEcCtD
Bexarotene—Nervous system disorder—Cisplatin—germ cell cancer	0.000511	0.00132	CcSEcCtD
Bexarotene—Cough—Etoposide—germ cell cancer	0.00051	0.00132	CcSEcCtD
Bexarotene—Thrombocytopenia—Cisplatin—germ cell cancer	0.00051	0.00132	CcSEcCtD
Bexarotene—Tachycardia—Cisplatin—germ cell cancer	0.000508	0.00131	CcSEcCtD
Bexarotene—Asthenia—Bleomycin—germ cell cancer	0.000507	0.00131	CcSEcCtD
Bexarotene—Skin disorder—Cisplatin—germ cell cancer	0.000506	0.00131	CcSEcCtD
Bexarotene—Hypertension—Etoposide—germ cell cancer	0.000505	0.0013	CcSEcCtD
Bexarotene—Hyperhidrosis—Cisplatin—germ cell cancer	0.000504	0.0013	CcSEcCtD
Bexarotene—Pruritus—Bleomycin—germ cell cancer	0.0005	0.00129	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—SOX2—germ cell cancer	0.0005	0.00232	CbGpPWpGaD
Bexarotene—Feeling abnormal—Ifosfamide—germ cell cancer	0.000498	0.00129	CcSEcCtD
Bexarotene—Chest pain—Etoposide—germ cell cancer	0.000498	0.00129	CcSEcCtD
Bexarotene—Eosinophilia—Methotrexate—germ cell cancer	0.000498	0.00129	CcSEcCtD
Bexarotene—Nausea—Vinblastine—germ cell cancer	0.000497	0.00128	CcSEcCtD
Bexarotene—Anorexia—Cisplatin—germ cell cancer	0.000497	0.00128	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000494	0.00128	CcSEcCtD
Bexarotene—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000494	0.00128	CcSEcCtD
Bexarotene—Pancreatitis—Methotrexate—germ cell cancer	0.000493	0.00127	CcSEcCtD
Bexarotene—Discomfort—Etoposide—germ cell cancer	0.000492	0.00127	CcSEcCtD
Bexarotene—Hypersensitivity—Dactinomycin—germ cell cancer	0.000486	0.00125	CcSEcCtD
Bexarotene—Confusional state—Etoposide—germ cell cancer	0.000481	0.00124	CcSEcCtD
Bexarotene—RXRA—Gene Expression—DNMT3L—germ cell cancer	0.000479	0.00222	CbGpPWpGaD
Bexarotene—Abdominal pain—Ifosfamide—germ cell cancer	0.000478	0.00123	CcSEcCtD
Bexarotene—Body temperature increased—Ifosfamide—germ cell cancer	0.000478	0.00123	CcSEcCtD
Bexarotene—Pancytopenia—Methotrexate—germ cell cancer	0.000477	0.00123	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000475	0.00123	CcSEcCtD
Bexarotene—Infection—Etoposide—germ cell cancer	0.000474	0.00122	CcSEcCtD
Bexarotene—Asthenia—Dactinomycin—germ cell cancer	0.000473	0.00122	CcSEcCtD
Bexarotene—Dysuria—Methotrexate—germ cell cancer	0.00047	0.00121	CcSEcCtD
Bexarotene—Neutropenia—Methotrexate—germ cell cancer	0.00047	0.00121	CcSEcCtD
Bexarotene—Paraesthesia—Cisplatin—germ cell cancer	0.000468	0.00121	CcSEcCtD
Bexarotene—Thrombocytopenia—Etoposide—germ cell cancer	0.000467	0.00121	CcSEcCtD
Bexarotene—Tachycardia—Etoposide—germ cell cancer	0.000466	0.0012	CcSEcCtD
Bexarotene—Dyspnoea—Cisplatin—germ cell cancer	0.000464	0.0012	CcSEcCtD
Bexarotene—Skin disorder—Etoposide—germ cell cancer	0.000464	0.0012	CcSEcCtD
Bexarotene—Erectile dysfunction—Methotrexate—germ cell cancer	0.000463	0.0012	CcSEcCtD
Bexarotene—Hyperhidrosis—Etoposide—germ cell cancer	0.000461	0.00119	CcSEcCtD
Bexarotene—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000459	0.00118	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000458	0.00213	CbGpPWpGaD
Bexarotene—Anorexia—Etoposide—germ cell cancer	0.000455	0.00117	CcSEcCtD
Bexarotene—Decreased appetite—Cisplatin—germ cell cancer	0.000453	0.00117	CcSEcCtD
Bexarotene—Diarrhoea—Dactinomycin—germ cell cancer	0.000451	0.00117	CcSEcCtD
Bexarotene—Pneumonia—Methotrexate—germ cell cancer	0.000451	0.00116	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00045	0.00116	CcSEcCtD
Bexarotene—Vomiting—Bleomycin—germ cell cancer	0.00045	0.00116	CcSEcCtD
Bexarotene—Rash—Bleomycin—germ cell cancer	0.000446	0.00115	CcSEcCtD
Bexarotene—Pain—Cisplatin—germ cell cancer	0.000445	0.00115	CcSEcCtD
Bexarotene—Dermatitis—Bleomycin—germ cell cancer	0.000445	0.00115	CcSEcCtD
Bexarotene—RXRA—Gene Expression—RARS—germ cell cancer	0.000445	0.00207	CbGpPWpGaD
Bexarotene—Hypersensitivity—Ifosfamide—germ cell cancer	0.000445	0.00115	CcSEcCtD
Bexarotene—Stomatitis—Methotrexate—germ cell cancer	0.000437	0.00113	CcSEcCtD
Bexarotene—Conjunctivitis—Methotrexate—germ cell cancer	0.000436	0.00113	CcSEcCtD
Bexarotene—Asthenia—Ifosfamide—germ cell cancer	0.000434	0.00112	CcSEcCtD
Bexarotene—Sweating—Methotrexate—germ cell cancer	0.00043	0.00111	CcSEcCtD
Bexarotene—Feeling abnormal—Cisplatin—germ cell cancer	0.000429	0.00111	CcSEcCtD
Bexarotene—Paraesthesia—Etoposide—germ cell cancer	0.000429	0.00111	CcSEcCtD
Bexarotene—Pruritus—Ifosfamide—germ cell cancer	0.000427	0.0011	CcSEcCtD
Bexarotene—Haematuria—Methotrexate—germ cell cancer	0.000427	0.0011	CcSEcCtD
Bexarotene—Dyspnoea—Etoposide—germ cell cancer	0.000425	0.0011	CcSEcCtD
Bexarotene—Somnolence—Etoposide—germ cell cancer	0.000424	0.0011	CcSEcCtD
Bexarotene—Epistaxis—Methotrexate—germ cell cancer	0.000423	0.00109	CcSEcCtD
Bexarotene—Nausea—Bleomycin—germ cell cancer	0.00042	0.00108	CcSEcCtD
Bexarotene—Vomiting—Dactinomycin—germ cell cancer	0.000419	0.00108	CcSEcCtD
Bexarotene—Rash—Dactinomycin—germ cell cancer	0.000416	0.00107	CcSEcCtD
Bexarotene—Decreased appetite—Etoposide—germ cell cancer	0.000415	0.00107	CcSEcCtD
Bexarotene—Diarrhoea—Ifosfamide—germ cell cancer	0.000413	0.00107	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000412	0.00106	CcSEcCtD
Bexarotene—Body temperature increased—Cisplatin—germ cell cancer	0.000412	0.00106	CcSEcCtD
Bexarotene—Fatigue—Etoposide—germ cell cancer	0.000411	0.00106	CcSEcCtD
Bexarotene—Pain—Etoposide—germ cell cancer	0.000408	0.00105	CcSEcCtD
Bexarotene—Constipation—Etoposide—germ cell cancer	0.000408	0.00105	CcSEcCtD
Bexarotene—Haemoglobin—Methotrexate—germ cell cancer	0.000404	0.00104	CcSEcCtD
Bexarotene—Haemorrhage—Methotrexate—germ cell cancer	0.000402	0.00104	CcSEcCtD
Bexarotene—Dizziness—Ifosfamide—germ cell cancer	0.0004	0.00103	CcSEcCtD
Bexarotene—Pharyngitis—Methotrexate—germ cell cancer	0.000399	0.00103	CcSEcCtD
Bexarotene—Urinary tract disorder—Methotrexate—germ cell cancer	0.000397	0.00103	CcSEcCtD
Bexarotene—Urethral disorder—Methotrexate—germ cell cancer	0.000394	0.00102	CcSEcCtD
Bexarotene—Feeling abnormal—Etoposide—germ cell cancer	0.000393	0.00102	CcSEcCtD
Bexarotene—Nausea—Dactinomycin—germ cell cancer	0.000392	0.00101	CcSEcCtD
Bexarotene—Gastrointestinal pain—Etoposide—germ cell cancer	0.00039	0.00101	CcSEcCtD
Bexarotene—Vomiting—Ifosfamide—germ cell cancer	0.000384	0.000992	CcSEcCtD
Bexarotene—Hypersensitivity—Cisplatin—germ cell cancer	0.000384	0.000991	CcSEcCtD
Bexarotene—Rash—Ifosfamide—germ cell cancer	0.000381	0.000984	CcSEcCtD
Bexarotene—Dermatitis—Ifosfamide—germ cell cancer	0.000381	0.000983	CcSEcCtD
Bexarotene—Body temperature increased—Etoposide—germ cell cancer	0.000377	0.000974	CcSEcCtD
Bexarotene—Abdominal pain—Etoposide—germ cell cancer	0.000377	0.000974	CcSEcCtD
Bexarotene—Eye disorder—Methotrexate—germ cell cancer	0.000376	0.000971	CcSEcCtD
Bexarotene—Tinnitus—Methotrexate—germ cell cancer	0.000375	0.000969	CcSEcCtD
Bexarotene—Asthenia—Cisplatin—germ cell cancer	0.000374	0.000965	CcSEcCtD
Bexarotene—Cardiac disorder—Methotrexate—germ cell cancer	0.000373	0.000964	CcSEcCtD
Bexarotene—Angiopathy—Methotrexate—germ cell cancer	0.000365	0.000943	CcSEcCtD
Bexarotene—Chills—Methotrexate—germ cell cancer	0.000361	0.000932	CcSEcCtD
Bexarotene—Nausea—Ifosfamide—germ cell cancer	0.000359	0.000927	CcSEcCtD
Bexarotene—Diarrhoea—Cisplatin—germ cell cancer	0.000356	0.00092	CcSEcCtD
Bexarotene—Alopecia—Methotrexate—germ cell cancer	0.000356	0.000918	CcSEcCtD
Bexarotene—Hypersensitivity—Etoposide—germ cell cancer	0.000352	0.000908	CcSEcCtD
Bexarotene—Malnutrition—Methotrexate—germ cell cancer	0.00035	0.000905	CcSEcCtD
Bexarotene—Erythema—Methotrexate—germ cell cancer	0.00035	0.000905	CcSEcCtD
Bexarotene—Dysgeusia—Methotrexate—germ cell cancer	0.000343	0.000886	CcSEcCtD
Bexarotene—Asthenia—Etoposide—germ cell cancer	0.000342	0.000884	CcSEcCtD
Bexarotene—RXRG—Gene Expression—H2AFZ—germ cell cancer	0.000342	0.00159	CbGpPWpGaD
Bexarotene—Back pain—Methotrexate—germ cell cancer	0.000339	0.000875	CcSEcCtD
Bexarotene—Pruritus—Etoposide—germ cell cancer	0.000338	0.000872	CcSEcCtD
Bexarotene—Vomiting—Cisplatin—germ cell cancer	0.000331	0.000855	CcSEcCtD
Bexarotene—Rash—Cisplatin—germ cell cancer	0.000328	0.000848	CcSEcCtD
Bexarotene—Dermatitis—Cisplatin—germ cell cancer	0.000328	0.000847	CcSEcCtD
Bexarotene—Diarrhoea—Etoposide—germ cell cancer	0.000327	0.000843	CcSEcCtD
Bexarotene—Ill-defined disorder—Methotrexate—germ cell cancer	0.000325	0.000839	CcSEcCtD
Bexarotene—Anaemia—Methotrexate—germ cell cancer	0.000324	0.000836	CcSEcCtD
Bexarotene—RXRB—Gene Expression—H2AFZ—germ cell cancer	0.000322	0.00149	CbGpPWpGaD
Bexarotene—Malaise—Methotrexate—germ cell cancer	0.000316	0.000816	CcSEcCtD
Bexarotene—Dizziness—Etoposide—germ cell cancer	0.000316	0.000815	CcSEcCtD
Bexarotene—Vertigo—Methotrexate—germ cell cancer	0.000315	0.000813	CcSEcCtD
Bexarotene—Leukopenia—Methotrexate—germ cell cancer	0.000314	0.00081	CcSEcCtD
Bexarotene—Nausea—Cisplatin—germ cell cancer	0.000309	0.000799	CcSEcCtD
Bexarotene—Cough—Methotrexate—germ cell cancer	0.000306	0.000789	CcSEcCtD
Bexarotene—Vomiting—Etoposide—germ cell cancer	0.000303	0.000784	CcSEcCtD
Bexarotene—Rash—Etoposide—germ cell cancer	0.000301	0.000777	CcSEcCtD
Bexarotene—Dermatitis—Etoposide—germ cell cancer	0.000301	0.000776	CcSEcCtD
Bexarotene—Headache—Etoposide—germ cell cancer	0.000299	0.000772	CcSEcCtD
Bexarotene—Arthralgia—Methotrexate—germ cell cancer	0.000298	0.00077	CcSEcCtD
Bexarotene—Chest pain—Methotrexate—germ cell cancer	0.000298	0.00077	CcSEcCtD
Bexarotene—Myalgia—Methotrexate—germ cell cancer	0.000298	0.00077	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000296	0.000765	CcSEcCtD
Bexarotene—Discomfort—Methotrexate—germ cell cancer	0.000295	0.000761	CcSEcCtD
Bexarotene—Confusional state—Methotrexate—germ cell cancer	0.000288	0.000744	CcSEcCtD
Bexarotene—Infection—Methotrexate—germ cell cancer	0.000284	0.000733	CcSEcCtD
Bexarotene—Nausea—Etoposide—germ cell cancer	0.000283	0.000732	CcSEcCtD
Bexarotene—Nervous system disorder—Methotrexate—germ cell cancer	0.00028	0.000724	CcSEcCtD
Bexarotene—Thrombocytopenia—Methotrexate—germ cell cancer	0.00028	0.000723	CcSEcCtD
Bexarotene—Skin disorder—Methotrexate—germ cell cancer	0.000278	0.000717	CcSEcCtD
Bexarotene—Hyperhidrosis—Methotrexate—germ cell cancer	0.000276	0.000714	CcSEcCtD
Bexarotene—Anorexia—Methotrexate—germ cell cancer	0.000272	0.000704	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.00026	0.000673	CcSEcCtD
Bexarotene—Insomnia—Methotrexate—germ cell cancer	0.000259	0.000668	CcSEcCtD
Bexarotene—Paraesthesia—Methotrexate—germ cell cancer	0.000257	0.000663	CcSEcCtD
Bexarotene—Dyspnoea—Methotrexate—germ cell cancer	0.000255	0.000658	CcSEcCtD
Bexarotene—Somnolence—Methotrexate—germ cell cancer	0.000254	0.000656	CcSEcCtD
Bexarotene—RXRA—Metabolism—SLC2A3—germ cell cancer	0.000254	0.00118	CbGpPWpGaD
Bexarotene—Dyspepsia—Methotrexate—germ cell cancer	0.000252	0.00065	CcSEcCtD
Bexarotene—RXRA—Metabolism—SLC22A3—germ cell cancer	0.00025	0.00116	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—AVP—germ cell cancer	0.00025	0.00116	CbGpPWpGaD
Bexarotene—Decreased appetite—Methotrexate—germ cell cancer	0.000248	0.000642	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000247	0.000637	CcSEcCtD
Bexarotene—Fatigue—Methotrexate—germ cell cancer	0.000246	0.000636	CcSEcCtD
Bexarotene—RXRG—Generic Transcription Pathway—MYC—germ cell cancer	0.000245	0.00114	CbGpPWpGaD
Bexarotene—Pain—Methotrexate—germ cell cancer	0.000244	0.000631	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	0.000242	0.00112	CbGpPWpGaD
Bexarotene—Feeling abnormal—Methotrexate—germ cell cancer	0.000236	0.000608	CcSEcCtD
Bexarotene—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000234	0.000604	CcSEcCtD
Bexarotene—RXRB—Generic Transcription Pathway—MYC—germ cell cancer	0.000231	0.00107	CbGpPWpGaD
Bexarotene—Abdominal pain—Methotrexate—germ cell cancer	0.000226	0.000584	CcSEcCtD
Bexarotene—Body temperature increased—Methotrexate—germ cell cancer	0.000226	0.000584	CcSEcCtD
Bexarotene—Hypersensitivity—Methotrexate—germ cell cancer	0.000211	0.000544	CcSEcCtD
Bexarotene—Asthenia—Methotrexate—germ cell cancer	0.000205	0.00053	CcSEcCtD
Bexarotene—RXRA—Metabolism—CRABP1—germ cell cancer	0.000204	0.000948	CbGpPWpGaD
Bexarotene—Pruritus—Methotrexate—germ cell cancer	0.000202	0.000522	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	0.000199	0.000923	CbGpPWpGaD
Bexarotene—Diarrhoea—Methotrexate—germ cell cancer	0.000196	0.000505	CcSEcCtD
Bexarotene—Dizziness—Methotrexate—germ cell cancer	0.000189	0.000488	CcSEcCtD
Bexarotene—Vomiting—Methotrexate—germ cell cancer	0.000182	0.000469	CcSEcCtD
Bexarotene—Rash—Methotrexate—germ cell cancer	0.00018	0.000465	CcSEcCtD
Bexarotene—Dermatitis—Methotrexate—germ cell cancer	0.00018	0.000465	CcSEcCtD
Bexarotene—Headache—Methotrexate—germ cell cancer	0.000179	0.000462	CcSEcCtD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000171	0.000794	CbGpPWpGaD
Bexarotene—Nausea—Methotrexate—germ cell cancer	0.00017	0.000439	CcSEcCtD
Bexarotene—RXRA—Gene Expression—H2AFZ—germ cell cancer	0.000168	0.000778	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—MYC—germ cell cancer	0.00012	0.000558	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—MYC—germ cell cancer	0.000118	0.000549	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—MYC—germ cell cancer	0.000111	0.000516	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC2A3—germ cell cancer	9.49e-05	0.000441	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC22A3—germ cell cancer	9.34e-05	0.000434	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—HRAS—germ cell cancer	8.89e-05	0.000413	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CRABP1—germ cell cancer	7.62e-05	0.000354	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC2A3—germ cell cancer	6.26e-05	0.000291	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC22A3—germ cell cancer	6.16e-05	0.000286	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—MYC—germ cell cancer	5.79e-05	0.000269	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CRABP1—germ cell cancer	5.02e-05	0.000233	CbGpPWpGaD
